PSYC Releases Debut Monthly Newsletter Micro-Dose Monthly
June 15 2020 - 8:30AM
InvestorsHub NewsWire
PSYC Releases Debut
Monthly Newsletter Micro-Dose Monthly
SAN DIEGO, CA -- June 15, 2020 --
InvestorsHub NewsWire -- Global Trac Solutions, Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce
that Psychedelic Spotlight has distributed to its subscribers the
first edition of its Micro-Dose Monthly newsletter as part of the
Company’s next step in developing its platform as a leading
communications channel for the emerging industry of medicinal
psychedelics. The newsletter is the culmination of the company’s
insights to introduce the important work being done within the
psychedelic space.
Not only are psychedelics showing
promise as FDA-designated “breakthrough therapies,” but they may
also be key to expanding consciousness through scientific
discoveries on how these substances interact with the brain, and
now, the accelerated progress of these studies have just created
unprecedented investment opportunities with the industry’s leading
companies going public this year. Psychedelics is providing hope
for millions with the potential to treat mental health
disorders.
The Micro-Dose Monthly newsletter,
written by Kent Sligh of PSYC, will provide thoughts on three
sections of the industry, which are medicinal progress,
lifestyle/entertainment, and investing
opportunities.
“Psychedelic medicine and the opportunities to invest in these
emerging therapies are all new to me, and it’s exciting to get a
chance to learn and write about such complex and vital subjects,”
said Kent Sligh. “After thousands of years as medicinal and
spiritual tools used in various cultures, to its
mid-20th century discovery by western scientists,
followed by criminalized classification and decades-long scientific
abandonment, psychedelics as medicine are finally experiencing
transformative and historic progress while creating a dynamic new
industry in the process. I believe, PSYC recognizes this as its
binding message in developing its original content and platform as
a reliable and intriguing source that attracts readers and
contributors, alike.”
“At a time when our world needs
hope and healing like never before, I believe that the newsletter
strikes the right tone and balance between application and
entertainment to introduce our subscribers to the re-emergence of
psychedelics as a global therapeutic,” said Jason LeBlanc, Global
Business Consultant. “We look forward to seeing where this journey
takes us.”
The Company encourages those who
are interested in receiving the newsletter, and those who wish to
stay current with the latest insights on trends and growth
associated with medicinal psychedelics, to subscribe at the
Psychedelic Spotlight homepage.
About Global Trac Solutions, Inc.
(OTC
Pink:PSYC)
Global Trac Solutions is a
diversified holding company dedicated to identifying new and
emerging industries. By utilizing our years of business development
expertise our diverse team of innovators continuously leverages our
experience to effectively execute go-to-market strategies in order
to position ourselves for rapid growth through the creation of an
evolving business foundation to enhance profitability
potential.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, investors are speculating that the psychedelic boom
could be bigger than that of cannabis. PSYC is your source for
current investment related news specific to psychedelic medicines
and cutting-edge research improving overall health, moving this
sector into the mainstream.
We believe in a forward-thinking
approach that embraces groundbreaking new technology and
innovations and through the vision of business development we
intend to continue to evolve into these unchartered territories as
the industry leaders of the future. We truly are the right TRAC to
follow.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com
website.
Corporate
Contact:
Global Trac Solutions, Inc.
(PSYC)
www.globaltracsolutions.com
(619) 925-3202
info@globaltracsolutions.com
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Aug 2024 to Sep 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Sep 2023 to Sep 2024